cbdMD公司近日向美国证券交易委员会提交了一份招股说明书补充文件，披露公司某持股股东可能通过公开市场转售其持有的普通股股份。根据文件显示，该股东计划出售的股份数量最高可达3,234,000股。
此次提交的招股说明书补充文件主要为潜在股份转售提供注册登记。文件明确说明，所有出售股份均来自现有股东，公司本身不会从此次交易中获得任何融资收益。该招股说明书生效后，持股股东可根据市场情况择机出售其登记股份。
值得注意的是，此次股份转售计划不会改变公司的已发行股份总数，也不会对公司的日常经营产生直接影响。cbdMD公司作为知名健康保健品企业，其股票在美国证券交易所的交易代码为YCBD。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.